JAK2V617F prevalence and allele burden in non-splanchnic venous thrombosis in the absence of overt myeloproliferative disorder

被引：24
作者：
Pardanani, A. [1 ]
Lasho, T. L. [1 ]
Schwager, S. [1 ]
Finke, C. [1 ]
Hussein, K. [1 ]
Pruthi, R. K. [1 ]
Tefferi, A. [1 ]
机构：
[1] Mayo Clin, Dept Med, Div Hematol, Rochester, MN 55905 USA
来源：
LEUKEMIA | 2007年 / 21卷 / 08期
关键词：
D O I：
10.1038/sj.leu.2404710
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1828 / 1829
页数：3
相关论文
共 7 条
  • [1] Latent myeloproliferative disorder revealed by the JAK2-V617F mutation and endogenous megakaryocytic colonies in patients with splanchnic vein thrombosis
    Boissinot, Marjorie
    Lippert, Eric
    Girodon, Francois
    Dobo, Irene
    Fouassier, Marc
    Masliah, Claude
    Praloran, Vincent
    Hermouet, Sylvie
    [J]. BLOOD, 2006, 108 (09) : 3223 - 3224
  • [2] Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status:: a prospective study
    Campbell, PJ
    Scott, LM
    Buck, G
    Wheatley, K
    East, CL
    Marsden, JT
    Duffy, A
    Boyd, EM
    Bench, AJ
    Scott, MA
    Vassiliou, GS
    Milligan, DW
    Smith, SR
    Erber, WN
    Bareford, D
    Wilkins, BS
    Reilly, JT
    Harrison, CN
    Green, AR
    [J]. LANCET, 2005, 366 (9501) : 1945 - 1953
  • [3] X-inactivation-based clonality analysis and quantitative JAK2V617F assessment reveal a strong association between clonality and JAK2V617F in PV but not ET/MMM, and identifies a subset of JAK2V617F-negative ET and NIMM patients with clonal hematopoiesis
    Levine, Ross L.
    Belisle, Claude
    Wadleigh, Martha
    Zahrieh, David
    Lee, Stephanie
    Chagnon, Pierre
    Gilliland, D. Gary
    Busque, Lambert
    [J]. BLOOD, 2006, 107 (10) : 4139 - 4141
  • [4] Prevalence of the activating JAK2 tyrosine kinase mutation V617F in the Budd-Chiari syndrome
    Patel, Raj K.
    Lea, Nicholas C.
    Heneghan, Michael A.
    Westwood, Nigel B.
    Milojkovic, Dragana
    Thanigaikumar, Murugaiyan
    Yallop, Deborah
    Arya, Roopen
    Pagliuca, Antonio
    Gaken, Joop
    Wendon, Julia
    Heaton, Nigel D.
    Mufti, Ghulam J.
    [J]. GASTROENTEROLOGY, 2006, 130 (07) : 2031 - 2038
  • [5] Role of the JAK2 mutation in the diagnosis of chronic myeloproliferative disorders in splanchnic vein thrombosis
    Primignani, Massimo
    Barosi, Giovanni
    Bergamaschi, Gaetano
    Gianelli, Umberto
    Fabris, Federica
    Reati, Raffaella
    Dell'Era, Alessandra
    Bucciarelli, Paolo
    Mannucci, Pier Mannuccio
    [J]. HEPATOLOGY, 2006, 44 (06) : 1528 - 1534
  • [6] The V617F mutation of JAK2 is very uncommon in patients with thrombosis
    Remacha, Angel F.
    Estivill, Camino
    Pilar Sarda, M.
    Mateo, Jose
    Carles Souto, Joan
    Canals, Carme
    Nomdedeu, Josep
    Fontcuberta, Jordi
    [J]. HAEMATOLOGICA, 2007, 92 (02) : 285 - 286
  • [7] JAK2 V617F mutation in classic chronic myeloproliferative diseases:: a report on a series of 349 patients
    Vizmanos, JL
    Ormazábal, C
    Larráyoz, MJ
    Cross, NCP
    Calasanz, MJ
    [J]. LEUKEMIA, 2006, 20 (03) : 534 - 535
1